Latest filing published 14 Mar 2022 for 康泰医学, €5.1M.
All filings by 王桂丽 on record concern 康泰医学, in the capacity of senior executive. We count 3 filings; the first trade dates from 16 November 2021 and the latest from 14 March 2022.
On the market, this insider has only sold: 3 sales, €8.4M in total. So far in 2022, the count stands at no purchases and 2 sales.
The newest entry dates from 14 March 2022: an open-market sale of €5.1M, in 康泰医学. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.